Conference Coverage

VIDEO: Device detects more atrial fibrillation, but when is intervention necessary?


 

AT THE INTERNATIONAL STROKE CONFERENCE

SAN DIEGO – After 6 months, Medtronic’s Reveal XT implant picked up atrial fibrillation in 8.6% of cryptogenic stroke patients. Standard monitoring found it in 1.4%, according to company data presented at the International Stroke Conference. Devices from Medtronic and other companies are going to make detection of asymptomatic atrial fibrillation more common, raising questions about when to intervene. Cardiologist Rod Passman, an investigator for the company, and neurologist Steven Greenberg shared their thoughts on the issue.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel .

Recommended Reading

Personalization keys vision of improved atrial fib care
MDedge Cardiology
Approaching ventricular arrhythmias in a structurally normal heart
MDedge Cardiology
Cooling the resuscitated sudden dead
MDedge Cardiology
CoreValve holds size advantage for U.S. TAVR
MDedge Cardiology
DECAAF published: Assess extent of fibrosis before AF ablation
MDedge Cardiology
New tools for stroke prediction in atrial fibrillation
MDedge Cardiology
Preventing cardiac neonatal lupus with hydroxychloroquine
MDedge Cardiology
Myocardial fibrosis assessment fine-tunes ICD selection
MDedge Cardiology
Ablation edges out drugs for treatment-naive paroxysmal atrial fibrillation
MDedge Cardiology
Continuous AF monitors raise questions about when to intervene
MDedge Cardiology

Related Articles